Alternative Isoform Regulation in Human Tissue Transcriptomes
Authors
Affiliations
Through alternative processing of pre-messenger RNAs, individual mammalian genes often produce multiple mRNA and protein isoforms that may have related, distinct or even opposing functions. Here we report an in-depth analysis of 15 diverse human tissue and cell line transcriptomes on the basis of deep sequencing of complementary DNA fragments, yielding a digital inventory of gene and mRNA isoform expression. Analyses in which sequence reads are mapped to exon-exon junctions indicated that 92-94% of human genes undergo alternative splicing, 86% with a minor isoform frequency of 15% or more. Differences in isoform-specific read densities indicated that most alternative splicing and alternative cleavage and polyadenylation events vary between tissues, whereas variation between individuals was approximately twofold to threefold less common. Extreme or 'switch-like' regulation of splicing between tissues was associated with increased sequence conservation in regulatory regions and with generation of full-length open reading frames. Patterns of alternative splicing and alternative cleavage and polyadenylation were strongly correlated across tissues, suggesting coordinated regulation of these processes, and sequence conservation of a subset of known regulatory motifs in both alternative introns and 3' untranslated regions suggested common involvement of specific factors in tissue-level regulation of both splicing and polyadenylation.
Chen Y, Davidson N, Kei Wan Y, Yao F, Su Y, Gamaarachchi H Nat Methods. 2025; .
PMID: 40082608 DOI: 10.1038/s41592-025-02623-4.
Deciphering the landscape of cis-acting sequences in natural yeast transcript leaders.
Akirtava C, May G, McManus C Nucleic Acids Res. 2025; 53(5).
PMID: 40071932 PMC: 11897887. DOI: 10.1093/nar/gkaf165.
PD-1 promotes tumor evasion via deregulating CD8 T cell function.
Zang H, Liu T, Wang X, Cheng S, Zhu X, Huang C J Immunother Cancer. 2025; 13(3).
PMID: 40050045 PMC: 11887316. DOI: 10.1136/jitc-2024-010529.
The potential impact of RNA splicing abnormalities on immune regulation in endometrial cancer.
Cao M, Yan J, Ding Y, Zhang Y, Sun Y, Jiang G Cell Death Dis. 2025; 16(1):148.
PMID: 40032844 PMC: 11876696. DOI: 10.1038/s41419-025-07458-7.
SUGP1 loss is the sole driver of SF3B1 hotspot mutant missplicing in cancer.
Xing P, Bak-Gordon P, Xie J, Zhang J, Liu Z, Manley J bioRxiv. 2025; .
PMID: 40027711 PMC: 11870612. DOI: 10.1101/2025.02.17.638713.